Literature DB >> 15964099

Hypothalamic rAAV-mediated GDNF gene delivery ameliorates age-related obesity.

Nihal Tümer1, Philip J Scarpace, M Devrim Dogan, Christopher S Broxson, Michael Matheny, David M Yurek, Carmen S Peden, Corinna Burger, Nicholas Muzyczka, Ronald J Mandel.   

Abstract

Intraventricular delivery of glial cell line-derived neurotrophic factor (GDNF) results in weight loss. We hypothesized that this effect of GDNF was likely mediated via its effects on dopaminergic neurons in the hypothalamus. Continuous rAAV-mediated GDNF expression in the hypothalamus of young and senescent rats resulted in weight loss compared to controls. However, GDNF-induced weight loss was unrelated to alterations in hypothalamic dopamine levels. The weight loss was associated with decreased food intake and increased energy expenditure, but these effects were not mediated by changes in hypothalamic NPY or POMC expression. Moreover, uncoupling protein 1 levels were unchanged in brown adipose tissue (BAT). The reduction in weight and adiposity were as great or greater in the aged rats even though aged rats are generally resistant to weight loss therapies. In summary, central GDNF gene delivery reduces weight and adiposity in young and aged rats through decreased food intake and increased energy expenditure. Our observations in aged rats suggest that GDNF may be especially effective in reducing obesity in aged obese rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964099     DOI: 10.1016/j.neurobiolaging.2005.03.018

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  16 in total

1.  Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease.

Authors:  Kc Biju; Qing Zhou; Guiming Li; Syed Z Imam; James L Roberts; William W Morgan; Robert A Clark; Senlin Li
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

2.  Glial cell line-derived neurotrophic factor protects against high-fat diet-induced obesity.

Authors:  Simon Musyoka Mwangi; Behtash Ghazi Nezami; Blessing Obukwelu; Mallappa Anitha; Smitha Marri; Ping Fu; Monica F Epperson; Ngoc-Anh Le; Malathy Shanmugam; Shanthi V Sitaraman; Yu-Hua Tseng; Frank A Anania; Shanthi Srinivasan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-23       Impact factor: 4.052

3.  Glial cell line-derived neurotrophic factor gene therapy ameliorates chronic hyperprolactinemia in senile rats.

Authors:  G R Morel; Y E Sosa; M J Bellini; N G Carri; S S Rodriguez; M C Bohn; R G Goya
Journal:  Neuroscience       Date:  2010-02-26       Impact factor: 3.590

4.  Widespread cortical expression of MANF by AAV serotype 7: localization and protection against ischemic brain injury.

Authors:  Mikko Airavaara; Matt J Chiocco; Doug B Howard; Katie L Zuchowski; Johan Peränen; Chao Liu; Shengyun Fang; Barry J Hoffer; Yun Wang; Brandon K Harvey
Journal:  Exp Neurol       Date:  2010-06-02       Impact factor: 5.330

5.  Age-Dependent Neurochemical Remodeling of Hypothalamic Astrocytes.

Authors:  Camila Leite Santos; Paola Haack Amaral Roppa; Pedro Truccolo; Fernanda Urruth Fontella; Diogo Onofre Souza; Larissa Daniele Bobermin; André Quincozes-Santos
Journal:  Mol Neurobiol       Date:  2017-10-04       Impact factor: 5.590

6.  Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery.

Authors:  Anja Drinkut; Yuliya Tereshchenko; Jörg B Schulz; Mathias Bähr; Sebastian Kügler
Journal:  Mol Ther       Date:  2011-11-15       Impact factor: 11.454

7.  Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.

Authors:  Brian P Mead; Namho Kim; G Wilson Miller; David Hodges; Panagiotis Mastorakos; Alexander L Klibanov; James W Mandell; Jay Hirsh; Jung Soo Suk; Justin Hanes; Richard J Price
Journal:  Nano Lett       Date:  2017-05-18       Impact factor: 11.189

8.  Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity.

Authors:  Fredric P Manfredsson; Nihal Tumer; Benedek Erdos; Tessa Landa; Christopher S Broxson; Layla F Sullivan; Aaron C Rising; Kevin D Foust; Yi Zhang; Nicholas Muzyczka; Oleg S Gorbatyuk; Philip J Scarpace; Ronald J Mandel
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

9.  Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector.

Authors:  Fredric P Manfredsson; Corinna Burger; Aaron C Rising; Kheir Zuobi-Hasona; Layla F Sullivan; Alfred S Lewin; Julia Huang; Emily Piercefield; Nicholas Muzyczka; Ronald J Mandel
Journal:  Mol Ther       Date:  2009-08-25       Impact factor: 11.454

10.  Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys.

Authors:  Xiaomin Su; Adrian P Kells; Eric J Huang; Han S Lee; Piotr Hadaczek; Janine Beyer; John Bringas; Philip Pivirotto; Janine Penticuff; Jamie Eberling; Howard J Federoff; John Forsayeth; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2009-12       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.